SEC Form D · filed January 3, 2022
Petros Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Andrew R. Gesek · New York, NYExecJoshua N. Silverman · New York, NYDirectorFady Boctor · New York, NYExecMitchell Arnold · New York, NYExecGregory T. Bradley · New York, NYDirectorWayne R. Walker · New York, NYDirectorJohn D. Shulman · New York, NYDirectorBruce T. Bernstein · New York, NYDirectorPatrick P. Bobby · BOISBRIAND, Quebec, CanadaDirectorDavid Deutsch · New York, NYExecXavier P. Montagne · BOISBRIAND, Quebec, CanadaDirectorLuisa P. Ingargiola · BOISBRIAND, Quebec, CanadaDirectorAlexandre Mongeon · BOISBRIAND, Quebec, CanadaExecMatthew Newman · San Juan, Puerto RicoDirectorSteve P. Barrenechea · BOISBRIAND, Quebec, CanadaExecKulwant Sandher · BOISBRIAND, Quebec, CanadaDirectorKristina J. Bradshaw · Columbus, OHExecBrian M. Gragnolati · Iowa City, IADirectorDaniel M. Krzmarzick · Iowa City, IAExecChristopher M. Klitgaard · Iowa City, IAExecKen M. Manning · Iowa City, IADirectorErika M. Crandall · San Francisco, CADirectorJoseph M. Varnas · San Francisco, CADirectorSteven M. Eisenberg · San Francisco, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗